Biotech Global Influenza Vaccine Market is Projected to Cross USD 14 Billion Mark by 2032 | DelveInsight February 21, 2025
Biotech BioArctic’s global license agreement with Bristol Myers Squibb for PyroGlutamate-amyloid-beta antibody program effective after antitrust clearance and closing February 20, 2025
Biotech Patented transdermal drug candidate from Vascarta may offer a convenient & cost-effective way to treat sickle cell disease February 19, 2025
Biotech Enzymatica AB Year-end report 2024: Strong performance in core markets – preparing for international growth February 18, 2025
Biotech Innovent Receives Second Fast Track Designation from the U.S. FDA for IBI363 (PD-1/IL-2α-bias Bispecific Antibody Fusion Protein) in Squamous Non-Small Cell Lung Cancer February 17, 2025
Biotech OraGen®, the first and only viable bone allograft, is now available for dental procedures February 16, 2025
Biotech Aramis Biotechnologies and the Biologics Manufacturing Centre Announce a Partnership February 15, 2025
Biotech DAAN Biotherapeutics Signs Antibody Exclusive Licensing Agreement with LigaChem Biosciences for ADC (Antibody-Drug Conjugate) Therapeutic Development February 13, 2025
Biotech Jazz Pharmaceuticals to Report 2024 Full Year and Fourth Quarter Financial Results on February 25, 2025 February 12, 2025